Germany’s Merck KGaA has signed a major collaboration agreement with Boston-based Valo Health, tapping into the biotech firm’s AI-powered drug discovery platform to advance research in Parkinson’s disease and related disorders. The deal could be worth more than $3 billion to Valo, the companies announced on Thursday.
20 Nov 2025-15:49
